Literature DB >> 8611169

Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression.

W Liao1, M Rudling, B Angelin.   

Abstract

Endotoxin induces hyperlipidaemia in experimental animals. In the current study, we investigated whether endotoxin alters hepatic low-density lipoprotein (LDL) receptor expression in rats. Endotoxin treatment suppressed hepatic LDL receptor expression in a dose- and time-dependent manner. Eighteen hours after intraperitoneal injection of increasing amounts of endotoxin, LDL receptor and its mRNA levels were determined by ligand blot and solution hybridization respectively. LDL receptor expression was inhibited by about 70% at a dose of 500 micrograms/100 g body weight. However, LDL receptor mRNA levels were markedly increased in all endotoxin-treated groups at this time point (by 83-136%; P < 0.001). Time-course experiments showed that LDL receptor expression was already reduced by 48% 4 h after endotoxin injection and was maximally reduced (by 63-65%) between 8 and 18 h. Changes in hepatic LDL receptor mRNA showed a different pattern. By 4 h after endotoxin injection, LDL receptor mRNA had decreased by 78% (P < 0.001). However, by 8 h after endotoxin injection, LDL receptor mRNA had returned to levels similar to controls, and 18 and 24 h after endotoxin injection, they were increased by about 60% (P < 0.05). Separation of plasma lipoproteins by FPLC demonstrated that endotoxin-induced changes in plasma triacylglycerols and cholesterol were due to accumulation of plasma apolipoprotein B-containing lipoproteins among very-low-density lipoprotein, intermediate-density lipoprotein and LDL. It is concluded that endotoxin suppresses hepatic LDL receptor expression in vivo in rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611169      PMCID: PMC1216992          DOI: 10.1042/bj3130873

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Endotoxins inhibit endocytotic catabolism of low-density lipoproteins in Hep G2 cells.

Authors:  W Liao; C H Florén
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

2.  Glucagon, cyclic AMP and adrenaline stimulate the degradation of low-density lipoprotein by cultured rat hepatocytes.

Authors:  N F Brown; A M Salter; R Fears; D N Brindley
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

3.  Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats.

Authors:  R A Scholl; C H Lang; G J Bagby
Journal:  J Surg Res       Date:  1984-11       Impact factor: 2.192

4.  Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters.

Authors:  K R Feingold; I Hardardottir; R Memon; E J Krul; A H Moser; J M Taylor; C Grunfeld
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

5.  Effects of gabexate mesilate on the reactions of lipid metabolism in endotoxic shock.

Authors:  F W Schmahl; R W Wabnitz; G Rox; K Drysch; G Richardt; E Poetter
Journal:  Adv Shock Res       Date:  1983

6.  Cholesterol metabolism in rat adrenal gland during reversible endotoxic shock.

Authors:  S Abarca; R García
Journal:  Eur J Biochem       Date:  1993-02-01

7.  Changes in serum lipoprotein pattern induced by acute infections.

Authors:  K Sammalkorpi; V Valtonen; Y Kerttula; E Nikkilä; M R Taskinen
Journal:  Metabolism       Date:  1988-09       Impact factor: 8.694

8.  Tumor necrosis factor up-regulates expression of low-density lipoprotein receptors on HepG2 cells.

Authors:  W Liao; C H Florén
Journal:  Hepatology       Date:  1993-05       Impact factor: 17.425

9.  Metabolic disorders of serum lipoproteins in endotoxin-poisoned mice: the role of high density lipoprotein (HDL) and triglyceride-rich lipoproteins.

Authors:  S Sakaguchi
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

10.  Triacylglycerol kinetics in endotoxic rats with suppressed lipoprotein lipase activity.

Authors:  G J Bagby; C B Corll; R R Martinez
Journal:  Am J Physiol       Date:  1987-07
View more
  4 in total

1.  Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.

Authors:  Kara N Maxwell; Edward A Fisher; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-27       Impact factor: 11.205

2.  Inflammation stimulates the expression of PCSK9.

Authors:  Kenneth R Feingold; Arthur H Moser; Judy K Shigenaga; Sophie M Patzek; Carl Grunfeld
Journal:  Biochem Biophys Res Commun       Date:  2008-07-16       Impact factor: 3.575

3.  Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor.

Authors:  Elena Topchiy; Mihai Cirstea; HyeJin Julia Kong; John H Boyd; Yingjin Wang; James A Russell; Keith R Walley
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

4.  Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells.

Authors:  Chuan-Jue Cui; Sha Li; Cheng-Gang Zhu; Jing Sun; Ying Du; Yan Zhang; Na-Qiong Wu; Yuan-Lin Guo; Rui-Xia Xu; Ying Gao; Jian-Jun Li
Journal:  J Cell Mol Med       Date:  2016-09-15       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.